Stocktoria
PRO DEX INC PDEX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1994-05-31
PRO DEX INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $66.6M | $53.8M | $46.1M | $42.0M | $38.0M |
| Gross profit | $19.5M | $14.6M | $12.7M | $13.1M | $13.6M |
| R&D expense | $3.6M | $3.2M | $2.8M | $3.0M | $4.4M |
| Operating income | $10.7M | $7.2M | $5.8M | $5.1M | $4.5M |
| Interest expense | — | — | $533,000 | $464,000 | $352,000 |
| Income tax | $3.1M | $507,000 | $2.4M | $1.1M | $1.4M |
| Net income | $9.0M | $2.1M | $7.1M | $4.6M | $6.2M |
| EPS (diluted) | $2.67 | $0.60 | $1.95 | $1.21 | $1.57 |
| Operating cash flow | -$1.7M | $6.2M | $5.5M | -$847,000 | -$2.1M |
| Free cash flow | — | — | — | -$2.5M | -$3.8M |
| Cash & equivalents | $33,000 | $2.6M | $2.9M | $849,000 | $3.7M |
| Inventory | $22.2M | $15.3M | $16.2M | $12.7M | $8.4M |
| Total assets | $61.2M | $52.5M | $51.8M | $49.1M | $40.3M |
| Total liabilities | $24.6M | $21.6M | $20.2M | $23.7M | $20.2M |
| Shareholders' equity | $36.6M | $30.9M | $31.6M | $25.4M | $21.1M |
Source: SEC EDGAR filings · CIK 0000788920 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.